Quiver Bioscience
Cambridge · Founded 2013
About Quiver Bioscience
Quiver Bioscience creates transformational medicines for patients with brain disorders. Utilizing human disease models and novel AI, the company aims to decode brain diseases and reimagine drug development. Quiver is technology-driven and focuses on uncovering new biology and novel therapeutic approaches. The company collaborates with various stakeholders to advance its mission of improving patient outcomes through innovative solutions.
Company Facts
- Founded: 2013
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $22.5M
- Last round: Grant (Jul 2025)
- Website: https://www.quiverbioscience.com
- Phone: +44 (617) 396-3611
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/quiver-bioscience-88532 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.